Etienne G C Brain (Etienne Brain)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 31

Top Topics

Epidermal Growth Factor Receptor

Placebo Controlled

Metastatic Breast Cancer

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Breast cancer research and treatment

This page only lists publications with an associated author ORCID identifier.

Publications

Patricia A Ganz, Hanna Bandos, Tanja Španić, Sue Friedman, Volkmar Mueller, Sherko Kuemmel, Suzette Delaloge, Etienne G C Brain, Masakazu Toi, Hideko Yamauchi, E Martínez de Dueñas, Anne Armstrong, Seock-Ah Im, Chuan-Gui Song, Hong Zheng, Tomasz Sarosiek, Priyanka Sharma, Cuizhi Geng, Peifen Fu, Kerstin Rhiem, Heike Frauchiger-Heuer, Pauline Wimberger, Daphné t'Kint de Roodenbeke, Ning Liao, Annabel Goodwin, Camille Chakiba-Brugère, Michael L Friedlander, Keun Seok Lee, Sylvie Giacchetti, Toshimi Takano, Fernando Henao, Shamsuddin Virani, Frances Valdes-Albini, Susan M Domchek, Charles Bane, Edward C McCarron, Monica Mita, Giovanna Rossi, Priya Rastogi, Anitra Fielding, Richard D Gelber, Elsemieke D Scheepers, David A Cameron, Judy E Garber, Charles E Geyer, Andrew N J Tutt
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g BRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Antoine Vasseur, Luc Cabel, Caroline Hego, Wissam Takka, Olfa Trabelsi Grati, Benjamin Renouf, Florence Lerebours, Delphine Loirat, Etienne G C Brain, Paul Cottu, Marie-Paule Sablin, Jean-Yves Pierga, Céline Callens, Shufang Renault, Francois-Clement Bidard
Fulvestrant and everolimus efficacy after CDK4/6 inhibitor: a prospective study with circulating tumor DNA analysis. Oncogene 43 (16) (2024)
Patricia A Ganz, Hanna Bandos, Tanja Španić, Sue Friedman, Volkmar Mueller, Sherko Kuemmel, Suzette Delaloge, Etienne G C Brain, Masakazu Toi, Hideko Yamauchi, E Martínez de Dueñas, Anne Armstrong, Seock-Ah Im, Chuan-Gui Song, Hong Zheng, Tomasz Sarosiek, Priyanka Sharma, Cuizhi Geng, Peifen Fu, Kerstin Rhiem, Heike Frauchiger-Heuer, Pauline Wimberger, Daphné t'Kint de Roodenbeke, Ning Liao, Annabel Goodwin, Camille Chakiba-Brugère, Michael L Friedlander, Keun Seok Lee, Sylvie Giacchetti, Toshimi Takano, Fernando Henao, Shamsuddin Virani, Frances Valdes-Albini, Susan M Domchek, Charles Bane, Edward C McCarron, Monica Mita, Giovanna Rossi, Priya Rastogi, Anitra Fielding, Richard D Gelber, Elsemieke D Scheepers, David A Cameron, Judy E Garber, Charles E Geyer, Andrew N J Tutt
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g BRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Antoine Vasseur, Luc Cabel, Caroline Hego, Wissam Takka, Olfa Trabelsi Grati, Benjamin Renouf, Florence Lerebours, Delphine Loirat, Etienne G C Brain, Paul Cottu, Marie-Paule Sablin, Jean-Yves Pierga, Céline Callens, Shufang Renault, Francois-Clement Bidard
Fulvestrant and everolimus efficacy after CDK4/6 inhibitor: a prospective study with circulating tumor DNA analysis. Oncogene 43 (16) (2024)
Patricia A Ganz, Hanna Bandos, Tanja Španić, Sue Friedman, Volkmar Mueller, Sherko Kuemmel, Suzette Delaloge, Etienne G C Brain, Masakazu Toi, Hideko Yamauchi, E Martínez de Dueñas, Anne Armstrong, Seock-Ah Im, Chuan-Gui Song, Hong Zheng, Tomasz Sarosiek, Priyanka Sharma, Cuizhi Geng, Peifen Fu, Kerstin Rhiem, Heike Frauchiger-Heuer, Pauline Wimberger, Daphné t'Kint de Roodenbeke, Ning Liao, Annabel Goodwin, Camille Chakiba-Brugère, Michael L Friedlander, Keun Seok Lee, Sylvie Giacchetti, Toshimi Takano, Fernando Henao, Shamsuddin Virani, Frances Valdes-Albini, Susan M Domchek, Charles Bane, Edward C McCarron, Monica Mita, Giovanna Rossi, Priya Rastogi, Anitra Fielding, Richard D Gelber, Elsemieke D Scheepers, David A Cameron, Judy E Garber, Charles E Geyer, Andrew N J Tutt
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g BRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Antoine Vasseur, Luc Cabel, Caroline Hego, Wissam Takka, Olfa Trabelsi Grati, Benjamin Renouf, Florence Lerebours, Delphine Loirat, Etienne G C Brain, Paul Cottu, Marie-Paule Sablin, Jean-Yves Pierga, Céline Callens, Shufang Renault, Francois-Clement Bidard
Fulvestrant and everolimus efficacy after CDK4/6 inhibitor: a prospective study with circulating tumor DNA analysis. Oncogene 43 (16) (2024)
Patricia A Ganz, Hanna Bandos, Tanja Španić, Sue Friedman, Volkmar Mueller, Sherko Kuemmel, Suzette Delaloge, Etienne G C Brain, Masakazu Toi, Hideko Yamauchi, E Martínez de Dueñas, Anne Armstrong, Seock-Ah Im, Chuan-Gui Song, Hong Zheng, Tomasz Sarosiek, Priyanka Sharma, Cuizhi Geng, Peifen Fu, Kerstin Rhiem, Heike Frauchiger-Heuer, Pauline Wimberger, Daphné t'Kint de Roodenbeke, Ning Liao, Annabel Goodwin, Camille Chakiba-Brugère, Michael L Friedlander, Keun Seok Lee, Sylvie Giacchetti, Toshimi Takano, Fernando Henao, Shamsuddin Virani, Frances Valdes-Albini, Susan M Domchek, Charles Bane, Edward C McCarron, Monica Mita, Giovanna Rossi, Priya Rastogi, Anitra Fielding, Richard D Gelber, Elsemieke D Scheepers, David A Cameron, Judy E Garber, Charles E Geyer, Andrew N J Tutt
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g BRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Patricia A Ganz, Hanna Bandos, Tanja Španić, Sue Friedman, Volkmar Mueller, Sherko Kuemmel, Suzette Delaloge, Etienne G C Brain, Masakazu Toi, Hideko Yamauchi, E Martínez de Dueñas, Anne Armstrong, Seock-Ah Im, Chuan-Gui Song, Hong Zheng, Tomasz Sarosiek, Priyanka Sharma, Cuizhi Geng, Peifen Fu, Kerstin Rhiem, Heike Frauchiger-Heuer, Pauline Wimberger, Daphné t'Kint de Roodenbeke, Ning Liao, Annabel Goodwin, Camille Chakiba-Brugère, Michael L Friedlander, Keun Seok Lee, Sylvie Giacchetti, Toshimi Takano, Fernando Henao, Shamsuddin Virani, Frances Valdes-Albini, Susan M Domchek, Charles Bane, Edward C McCarron, Monica Mita, Giovanna Rossi, Priya Rastogi, Anitra Fielding, Richard D Gelber, Elsemieke D Scheepers, David A Cameron, Judy E Garber, Charles E Geyer, Andrew N J Tutt
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g BRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Antoine Vasseur, Luc Cabel, Caroline Hego, Wissam Takka, Olfa Trabelsi Grati, Benjamin Renouf, Florence Lerebours, Delphine Loirat, Etienne G C Brain, Paul Cottu, Marie-Paule Sablin, Jean-Yves Pierga, Céline Callens, Shufang Renault, Francois-Clement Bidard
Fulvestrant and everolimus efficacy after CDK4/6 inhibitor: a prospective study with circulating tumor DNA analysis. Oncogene (2024)
Patricia A Ganz, Hanna Bandos, Tanja Španić, Sue Friedman, Volkmar Mueller, Sherko Kuemmel, Suzette Delaloge, Etienne G C Brain, Masakazu Toi, Hideko Yamauchi, E Martínez de Dueñas, Anne Armstrong, Seock-Ah Im, Chuan-Gui Song, Hong Zheng, Tomasz Sarosiek, Priyanka Sharma, Cuizhi Geng, Peifen Fu, Kerstin Rhiem, Heike Frauchiger-Heuer, Pauline Wimberger, Daphné t'Kint de Roodenbeke, Ning Liao, Annabel Goodwin, Camille Chakiba-Brugère, Michael L Friedlander, Keun Seok Lee, Sylvie Giacchetti, Toshimi Takano, Fernando Henao, Shamsuddin Virani, Frances Valdes-Albini, Susan M Domchek, Charles Bane, Edward C McCarron, Monica Mita, Giovanna Rossi, Priya Rastogi, Anitra Fielding, Richard D Gelber, Elsemieke D Scheepers, David A Cameron, Judy E Garber, Charles E Geyer, Andrew N J Tutt
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g BRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Antoine Vasseur, Luc Cabel, Caroline Hego, Wissam Takka, Olfa Trabelsi Grati, Benjamin Renouf, Florence Lerebours, Delphine Loirat, Etienne G C Brain, Paul Cottu, Marie-Paule Sablin, Jean-Yves Pierga, Céline Callens, Shufang Renault, Francois-Clement Bidard
Fulvestrant and everolimus efficacy after CDK4/6 inhibitor: a prospective study with circulating tumor DNA analysis. Oncogene 43 (16) (2024)
Patricia A Ganz, Hanna Bandos, Tanja Španić, Sue Friedman, Volkmar Mueller, Sherko Kuemmel, Suzette Delaloge, Etienne G C Brain, Masakazu Toi, Hideko Yamauchi, E Martínez de Dueñas, Anne Armstrong, Seock-Ah Im, Chuan-Gui Song, Hong Zheng, Tomasz Sarosiek, Priyanka Sharma, Cuizhi Geng, Peifen Fu, Kerstin Rhiem, Heike Frauchiger-Heuer, Pauline Wimberger, Daphné t'Kint de Roodenbeke, Ning Liao, Annabel Goodwin, Camille Chakiba-Brugère, Michael L Friedlander, Keun Seok Lee, Sylvie Giacchetti, Toshimi Takano, Fernando Henao, Shamsuddin Virani, Frances Valdes-Albini, Susan M Domchek, Charles Bane, Edward C McCarron, Monica Mita, Giovanna Rossi, Priya Rastogi, Anitra Fielding, Richard D Gelber, Elsemieke D Scheepers, David A Cameron, Judy E Garber, Charles E Geyer, Andrew N J Tutt
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g BRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Patricia A Ganz, Hanna Bandos, Tanja Španić, Sue Friedman, Volkmar Mueller, Sherko Kuemmel, Suzette Delaloge, Etienne G C Brain, Masakazu Toi, Hideko Yamauchi, E Martínez de Dueñas, Anne Armstrong, Seock-Ah Im, Chuan-Gui Song, Hong Zheng, Tomasz Sarosiek, Priyanka Sharma, Cuizhi Geng, Peifen Fu, Kerstin Rhiem, Heike Frauchiger-Heuer, Pauline Wimberger, Daphné t'Kint de Roodenbeke, Ning Liao, Annabel Goodwin, Camille Chakiba-Brugère, Michael L Friedlander, Keun Seok Lee, Sylvie Giacchetti, Toshimi Takano, Fernando Henao, Shamsuddin Virani, Frances Valdes-Albini, Susan M Domchek, Charles Bane, Edward C McCarron, Monica Mita, Giovanna Rossi, Priya Rastogi, Anitra Fielding, Richard D Gelber, Elsemieke D Scheepers, David A Cameron, Judy E Garber, Charles E Geyer, Andrew N J Tutt
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g BRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Patricia A Ganz, Hanna Bandos, Tanja Španić, Sue Friedman, Volkmar Mueller, Sherko Kuemmel, Suzette Delaloge, Etienne G C Brain, Masakazu Toi, Hideko Yamauchi, E Martínez de Dueñas, Anne Armstrong, Seock-Ah Im, Chuan-Gui Song, Hong Zheng, Tomasz Sarosiek, Priyanka Sharma, Cuizhi Geng, Peifen Fu, Kerstin Rhiem, Heike Frauchiger-Heuer, Pauline Wimberger, Daphné t'Kint de Roodenbeke, Ning Liao, Annabel Goodwin, Camille Chakiba-Brugère, Michael L Friedlander, Keun Seok Lee, Sylvie Giacchetti, Toshimi Takano, Fernando Henao, Shamsuddin Virani, Frances Valdes-Albini, Susan M Domchek, Charles Bane, Edward C McCarron, Monica Mita, Giovanna Rossi, Priya Rastogi, Anitra Fielding, Richard D Gelber, Elsemieke D Scheepers, David A Cameron, Judy E Garber, Charles E Geyer, Andrew N J Tutt
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g BRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Etienne G C Brain
Systemic Therapy in Older Patients With High-Risk Disease. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 43 (2023)
Hope S Rugo, Catherine H Van Poznak, Patrick Neven, Iwona Danielewicz, Soo-Chin Lee, Mario Campone, Jeannie Y K Chik, Estela Vega Alonso, Bjørn Naume, Etienne G C Brain, Jonathan M Siegel, Rui Li, Deise Uema, Volker J Wagner, Robert E Coleman
Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials. Breast cancer research and treatment 204 (2) (2023)
Francois-Clement Bidard, Nicolas Kiavue, William Jacot, Thomas Bachelot, Sylvain Dureau, Hughes Bourgeois, Anthony Goncalves, Etienne G C Brain, Sylvain Ladoire, Florence Dalenc, Joseph Gligorov, Luis Teixeira, George Emile, Jean-Marc Ferrero, Delphine Loirat, Luc Cabel, Amir Kadi, Véronique Diéras, Catherine Alix-Panabières, Jean-Yves Pierga
Overall Survival With Circulating Tumor Cell Count-Driven Choice of Therapy in Advanced Breast Cancer: A Randomized Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Hope S Rugo, Catherine H Van Poznak, Patrick Neven, Iwona Danielewicz, Soo-Chin Lee, Mario Campone, Jeannie Y K Chik, Estela Vega Alonso, Bjørn Naume, Etienne G C Brain, Jonathan M Siegel, Rui Li, Deise Uema, Volker J Wagner, Robert E Coleman
Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials. Breast cancer research and treatment 204 (2) (2023)
Hope S Rugo, Catherine H Van Poznak, Patrick Neven, Iwona Danielewicz, Soo-Chin Lee, Mario Campone, Jeannie Y K Chik, Estela Vega Alonso, Bjørn Naume, Etienne G C Brain, Jonathan M Siegel, Rui Li, Deise Uema, Volker J Wagner, Robert E Coleman
Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials. Breast cancer research and treatment 204 (2) (2023)
Hans P M W Wildiers, Anne C Armstrong, Eveline Cuypere, Florence Dalenc, Luc Dirix, Stephen Chan, Frederic Marmé, Carolina P Schröder, Jens Huober, Fran Ois P Duhoux, Peter Vuylsteke, Agnes Jager, Etienne G C Brain, Sherko Kuemmel, Zsuzsanna Pápai, Catharina Willemien Menke-van der Houven van Oordt, Luca Perjesi, Christian Mueller, Chrystelle Brignone, Frederic Triebel
Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase 2b Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Hope S Rugo, Catherine H Van Poznak, Patrick Neven, Iwona Danielewicz, Soo-Chin Lee, Mario Campone, Jeannie Y K Chik, Estela Vega Alonso, Bjørn Naume, Etienne G C Brain, Jonathan M Siegel, Rui Li, Deise Uema, Volker J Wagner, Robert E Coleman
Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials. Breast cancer research and treatment 204 (2) (2023)
Hope S Rugo, Catherine H Van Poznak, Patrick Neven, Iwona Danielewicz, Soo-Chin Lee, Mario Campone, Jeannie Y K Chik, Estela Vega Alonso, Bjørn Naume, Etienne G C Brain, Jonathan M Siegel, Rui Li, Deise Uema, Volker J Wagner, Robert E Coleman
Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials. Breast cancer research and treatment (2023)
Amélie Mallet, Amélie Lusque, Christelle Levy, Barbara Pistilli, Etienne G C Brain, David Pasquier, Marc Debled, Jean Christophe Thery, Anthony Gonçalves, Isabelle Desmoulins, Thibault De La Motte Rouge, Christelle Faure, Jean Marc Ferrero, Jean Christophe Eymard, Marie Ange Mouret-Reynier, Anne Patsouris, Paul Cottu, Florence Dalenc, Thierry Petit, Olivier Payen, Lionel Uwer, Séverine Guiu, Jean-Sébastien Frenel
Real-world evidence of the management and prognosis of young women (⩽40 years) with de novo metastatic breast cancer. Therapeutic advances in medical oncology 14 (2022)
Didier Verhoeven, Claudia Allemani, Cary Kaufman, Sabine Siesling, Manuela A Joore, Etienne G C Brain, Mauricio Magalhães Costa
New Frontiers for Fairer Breast Cancer Care in a Globalized World. European journal of breast health 17 (2) (2021)
Nadia Oubaya, Pierre Soubeyran, Nicoleta Reinald, Marianne Fonck, Mylène Allain, Sonia Zebachi, Damien Heitz, Marie Laurent, Cécile Delattre, Philippe Caillet, Jérôme Dauba, Sylvie Bastuji-Garin, Gilles Albrand, Michael Bringuier, Muriel Rainfray, Etienne G C Brain, Thomas Grellety, Elena Paillaud, Simone Mathoulin-Pélissier, Jean-Yves Blay, Florence Canouï-Poitrine
Prognostic Value of Routinely Measured Inflammatory Biomarkers in Older Cancer Patients: Pooled Analysis of Three Cohorts. Cancers 13 (24) (2021)
Thomas Grinda, Natacha Joyon, Amélie Lusque, Sarah Lefèvre, Laurent Arnould, Frédérique Penault-Llorca, Gaëtan Macgrogan, Isabelle Treilleux, Anne-Vincent Salomon, Juliette Haudebourg, Aurélie Maran-Gonzalez, Emmanuelle Charafe-Jauffret, Coralie Courtinard, Camille Franchet, Véronique Verriele, Etienne G C Brain, Patrick Tas, Cécile Blanc-Fournier, Agnès Leroux, Delphine Loussouarn, Anca Berghian, Eva Brabencova, Jean Pierre Ghnassia, Jean-Yves Scoazec, Suzette Delaloge, Thomas Filleron, Magali Lacroix-Triki
Phenotypic discordance between primary and metastatic breast cancer in the large-scale real-life multicenter French ESME cohort. NPJ breast cancer 7 (1) (2021)
Sandra Ortiz-Cuaran, Laura Mezquita, Aurélie Swalduz, Mihalea Aldea, Julien Mazieres, Camille Leonce, Cecile Jovelet, Anne Pradines, Virginie Avrillon, Washington R Chumbi Flores, Ludovic Lacroix, Yohann Loriot, Virginie Westeel, Maud Ngo-Camus, Claire Tissot, Christine Raynaud, Radj Gervais, Etienne G C Brain, Isabelle Monnet, Etienne Giroux Leprieur, Caroline Caramella, Celine Mahier-Aït Oukhatar, Natalie Hoog-Labouret, Frank de Kievit, Karen Howarth, Clive Morris, Emma Green, Luc Friboulet, Sylvie Chabaud, Jean-François Guichou, Maurice Pérol, Benjamin Besse, Jean Yves Blay, Pierre Saintigny, David Planchard
Circulating Tumor DNA Genomics Reveal Potential Mechanisms of Resistance to BRAF-Targeted Therapies in Patients with BRAF-Mutant Metastatic Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (23) (2020)
Elena López-Miranda, José Manuel Pérez-García, Serena Di Cosimo, Etienne G C Brain, Maja Ravnik, Santiago Escriva-de-Romani, María Jesús Vidal Losada, Joseph Gligorov, Simona Borštnar, Laura Calabuig, Miguel Sampayo-Cordero, Andrea Malfettone, Antonio Llombart-Cussac, Thomas M Suter, Javier Cortés
Trastuzumab Emtansine Plus Non-Pegylated Liposomal Doxorubicin in HER2-Positive Metastatic Breast Cancer (Thelma): A Single-Arm, Multicenter, Phase Ib Trial. Cancers 12 (12) (2020)
Junien Sirieix, Julien Fraisse, Simone Mathoulin-Pelissier, Marianne Leheurteur, Laurence Vanlemmens, Christelle Jouannaud, Véronique Diéras, Christelle Lévy, Mony Ung, Marie-Ange Mouret-Reynier, Thierry Petit, Bruno Coudert, Etienne G C Brain, Barbara Pistilli, Jean-Marc Ferrero, Anthony Goncalves, Lionel Uwer, Anne Patsouris, Olivier Tredan, Coralie Courtinard, Sophie Gourgou, Jean-Sébastien Frenel
Management and outcome of male metastatic breast cancer in the national multicenter observational research program Epidemiological Strategy and Medical Economics (ESME). Therapeutic advances in medical oncology 12 (2020)
Beatriz Grandal, Clémence Evrevin, Enora Laas, Isabelle Jardin, Sonia Rozette, Lucie Laot, Elise Dumas, Florence Coussy, Jean-Yves Pierga, Etienne G C Brain, Claire Saule, Dominique Stoppa-Lyonnet, Sophie Frank, Claire Sénéchal, Marick Lae, Diane De Croze, Guillaume Bataillon, Julien Guerin, Fabien Reyal, Anne-Sophie Hamy
Impact of BRCA Mutation Status on Tumor Infiltrating Lymphocytes (TILs), Response to Treatment, and Prognosis in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy. Cancers 12 (12) (2020)
Jocelyn Gal, Gérard Milano, Patrick Brest, Nathalie Ebran, Julia Gilhodes, Laurence Llorca, Coraline Dubot, Gilles Romieu, Isabelle Desmoulins, Etienne G C Brain, Anthony Goncalves, Jean-Marc Ferrero, Paul-Henri Cottu, Marc Debled, Olivier Tredan, Emmanuel Chamorey, Marco Carlo Merlano, Jérôme Lemonnier, Marie-Christine Etienne-Grimaldi, Jean-Yves Pierga
VEGF-Related Germinal Polymorphisms May Identify a Subgroup of Breast Cancer Patients with Favorable Outcome under Bevacizumab-Based Therapy-A Message from COMET, a French Unicancer Multicentric Study. Pharmaceuticals (Basel, Switzerland) 13 (11) (2020)